REGENXBIO Inc. (RGNX)

REGENXBIO Revenue

REGENXBIO had revenue of $6.39M in the quarter ending March 31, 2026, a decrease of -92.82%. This brings the company's revenue in the last twelve months to $87.82M, down -43.96% year-over-year. In the year 2025, REGENXBIO had annual revenue of $170.44M with 104.54% growth.

• Revenue (ttm): $87.82M
• Revenue Growth: -43.96%
• P/S Ratio: 4.20
• Revenue / Employee: $236,717
• Employees: 371
• Market Cap: 341.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	170.44M	87.11M	104.54%
Dec 31, 2024	83.33M	-6.91M	-7.66%
Dec 31, 2023	90.24M	-22.48M	-19.94%
Dec 31, 2022	112.72M	-357.62M	-76.03%
Dec 31, 2021	470.35M	315.78M	204.30%
Dec 31, 2020	154.57M	119.33M	338.70%
Dec 31, 2019	35.23M	-183.27M	-83.88%
Dec 31, 2018	218.51M	208.11M	2,002.42%
Dec 31, 2017	10.39M	5.80M	126.48%
Dec 31, 2016	4.59M	-3.00M	-39.52%
Dec 31, 2015	7.59M	1.47M	23.99%
Dec 31, 2014	6.12M	33.00K	0.54%
Dec 31, 2013	6.09M	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error